Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Dhamrait, J. Stephens, J. Cooper, J. Acharya, A. Mani, K. Moore, G. Miller, S. Humphries, S. Hurel, H. Montgomery (2004)
Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2.European heart journal, 25 6
D. Stram (2005)
Software for tag single nucleotide polymorphism selectionHuman Genomics, 2
D. Tregouet, S. Barbaux, S. Escolano, N. Tahri, J. Golmard, L. Tiret, F. Cambien (2002)
Specific haplotypes of the P-selectin gene are associated with myocardial infarction.Human molecular genetics, 11 17
B. Rosengren, H. Peilot, M. Umaerus, A. Jönsson-Rylander, L. Mattsson-Hulten, C. Hallberg, P. Cronet, Mariam Rodríguez-Lee, E. Hurt-Camejo (2006)
Secretory Phospholipase A2 Group V: Lesion Distribution, Activation by Arterial Proteoglycans, and Induction in Aorta by a Western DietArteriosclerosis, Thrombosis, and Vascular Biology, 26
B. Ivandic, L. Castellani, Xuping Wang, J. Qiao, M. Mehrabian, M. Navab, A. Fogelman, D. Grass, M. Swanson, M. Beer, F. Beer, A. Lusis (1999)
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.Arteriosclerosis, thrombosis, and vascular biology, 19 5
E. Dennis (1994)
Diversity of group types, regulation, and function of phospholipase A2.The Journal of biological chemistry, 269 18
K. Kugiyama, Y. Ota, Seigo Sugiyama, Hiroaki Kawano, H. Doi, H. Soejima, S. Miyamoto, Hisao Ogawa, K. Takazoe, Hirofumi Yasue (2000)
Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.The American journal of cardiology, 86 7
N. Galeano, M. Al-Haideri, Fannie Keyserman, S. Rumsey, Richard Deckelbaum (1998)
Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity.Journal of lipid research, 39 6
Shirley Miller, D. Dykes, H. Polesky (1988)
A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic acids research, 16 3
J. Tischfield, Y. Xia, D. Shih, I. Klisak, J. Chen, S. Engle, A. Siakotos, M. Winstead, J. Seilhamer, V. Allamand, G. Gyapay, A. Lusis (1996)
Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human.Genomics, 32 3
W. Jaross, R. Eckey, M. Menschikowski (2002)
Biological effects of secretory phospholipase A2 group IIA on lipoproteins and in atherogenesisEuropean Journal of Clinical Investigation, 32
M. Sampson, N. Gopaul, I. Davies, D. Hughes, M. Carrier (2002)
Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes.Diabetes care, 25 3
(2001)
Phospholipase A(2) in vascular disease
K. Kim, S. Han, M. Hong, W. Cho (2000)
The molecular basis of phosphatidylcholine preference of human group-V phospholipase A2.The Biochemical journal, 348 Pt 3
T. Perneger (1999)
Adjusting for multiple testing in studies is less important than other concernsBMJ, 318
M. Stephens, N. Smith, P. Donnelly (2001)
A new statistical method for haplotype reconstruction from population data.American journal of human genetics, 68 4
P. Sartipy, B. Johansen, G. Camejo, B. Rosengren, G. Bondjers, E. Hurt-Camejo (1996)
Binding of Human Phospholipase A2 Type II to ProteoglycansThe Journal of Biological Chemistry, 271
R. Krauss, D. Burke (1982)
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.Journal of lipid research, 23 1
Meredith Bostrom, B. Boyanovsky, C. Jordan, M. Wadsworth, D. Taatjes, F. Beer, N. Webb (2007)
Group V Secretory Phospholipase A2 Promotes Atherosclerosis: Evidence From Genetically Altered MiceArteriosclerosis, Thrombosis, and Vascular Biology, 27
N. Webb (2005)
Secretory phospholipase A2 enzymes in atherogenesisCurrent Opinion in Lipidology, 16
B. Rosengren, A. Jönsson-Rylander, H. Peilot, G. Camejo, E. Hurt-Camejo (2006)
Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis.Biochimica et biophysica acta, 1761 11
S. Boekholdt, T. Keller, N. Wareham, R. Luben, S. Bingham, N. Day, M. Sandhu, J. Jukema, J. Kastelein, C. Hack, K. Khaw (2005)
Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population StudyArteriosclerosis, Thrombosis, and Vascular Biology, 25
K. Alberti, P. Zimmet (1998)
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 15
Z. Mallat, P. Steg, J. Bénessiano, M. Tanguy, K. Fox, J. Collet, O. Dabbous, P. Henry, K. Carruthers, Anne Dauphin, Carla Arguelles, J. Masliah, B. Hugel, G. Montalescot, J. Freyssinet, B. Asselain, A. Tedgui (2005)
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.Journal of the American College of Cardiology, 46 7
D. Tregouet, S. Ricard, V. Nicaud, I. Arnould, S. Soubigou, Marie Rosier, N. Duverger, O. Poirier, S. Macé, F. Kee, C. Morrison, P. Denéfle, L. Tiret, A. Evans, J. Deleuze, F. Cambien (2004)
In-Depth Haplotype Analysis of ABCA1 Gene Polymorphisms in Relation to Plasma ApoA1 Levels and Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 24
L. Elinder, A. Dumitrescu, P. Larsson, U. Hedin, J. Frostegård, H. Claesson (1997)
Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall.Arteriosclerosis, thrombosis, and vascular biology, 17 10
K. Kugiyama, Y. Ota, K. Takazoe, Y. Moriyama, H. Kawano, Y. Miyao, T. Sakamoto, H. Soejima, H. Ogawa, H. Doi, S. Sugiyama, H. Yasue (1999)
Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease.Circulation, 100 12
P. Wootton, F. Drenos, J. Cooper, S. Thompson, J. Stephens, E. Hurt-Camejo, O. Wiklund, S. Humphries, P. Talmud (2006)
Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study.Human molecular genetics, 15 2
Sartipy (1996)
Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activityJ. Biol. Chem., 271
N. Leitinger, A. Watson, S. Hama, B. Ivandic, J. Qiao, J. Huber, K. Faull, D. Grass, M. Navab, A. Fogelman, F. Beer, A. Lusis, J. Berliner (1999)
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.Arteriosclerosis, thrombosis, and vascular biology, 19 5
E. Hurt-Camejo, S. Andersen, R. Standal, B. Rosengren, P. Sartipy, Elizabeth Stadberg, B. Johansen (1997)
Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins.Arteriosclerosis, thrombosis, and vascular biology, 17 2
Yoshiyuki Satake, B. Diaz, B. Balestrieri, B. Lam, Y. Kanaoka, M. Grusby, J. Arm (2004)
Role of Group V Phospholipase A2 in Zymosan-induced Eicosanoid Generation and Vascular Permeability Revealed by Targeted Gene Disruption*Journal of Biological Chemistry, 279
K. Rothman (1990)
No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1
W. Pruzanski, L. Lambeau, M. Lazdunsky, W. Cho, J. Kopilov, A. Kuksis (2005)
Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.Biochimica et biophysica acta, 1736 1
I. Day, S. Humphries, S. Richards, D. Norton, M. Reid (1995)
High-throughput genotyping using horizontal polyacrylamide gels with wells arranged for microplate array diagonal gel electrophoresis (MADGE).BioTechniques, 19 5
Scheffer (2003)
Associations of LDL size withDiabet. Med., 20
(2004)
An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes
P. Sartipy, G. Camejo, L. Svensson, E. Hurt-Camejo (1999)
Phospholipase A2 Modification of Low Density Lipoproteins Forms Small High Density Particles with Increased Affinity for Proteoglycans and Glycosaminoglycans*The Journal of Biological Chemistry, 274
P. Scheffer, G. Bos, H. Volwater, J.J.M. Dekker, Robert Heine, Tom Teerlink (2003)
Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patientsDiabetic Medicine, 20
Animal and human studies suggest that both secretory PLA2 (sPLA2)-V and sPLA2-IIA (encoded, respectively, by the neighbouring PLA2G5 and PLA2G2A genes) contribute to atherogenesis. Elevated plasma sPLA2-IIA predicts coronary heart disease (CHD) risk, but no mass assay for sPLA2-V is available. We previously reported that tagging single nucleotide polymorphism (tSNP) haplotypes of PLA2G2A are strongly associated with sPLA2-IIA mass, but not lipid levels. Here, we use tSNPs of the sPLA2-V gene to investigate the association of PLA2G5 with CHD risk markers. Seven PLA2G5 tSNPs genotypes, explaining >92 of the locus genetic variability, were determined in 519 patients with Type II diabetes (in whom PLA2G2A tSNP data was available), and defined seven common haplotypes (frequencies >5). PLA2G5 and PLA2G2A tSNPs showed linkage disequilibrium (LD). Compared to the common PLA2G5 haplotype, H1 (frequency 34.9), haplotypes H27 were associated with overall higher plasma LDL (P < 0.00004) and total cholesterol (P < 0.00003) levels yet lower oxLDL/LDL (P 0.006) and sPLA2-IIA mass (P 0.04), probably reflecting LD with PLA2G2A. Intronic tSNP (rs11573248), unlikely itself to be functional, distinguished H1 from LDL-raising haplotypes and may mark a functional site. In conclusion, PLA2G5 tSNP haplotypes demonstrate an association with total and LDL cholesterol and oxLDL/LDL, not seen with PLA2G2A, thus confirming distinct functional roles for these two sPLA2s.
Human Molecular Genetics – Oxford University Press
Published: Jun 15, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.